JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

Final dividend in bonus shares for the year ended December 31, 2022

Final dividend in bonus shares for the year ended December 31, 2022

Final dividend in cash for the year ended December 31, 2022

Final dividend in cash for the year ended December 31, 2022

TERMS OF REFERENCE OF THE REMUNERATION AND EVALUATION COMMITTEE OF THE BOARD OF DIRECTORS

TERMS OF REFERENCE OF THE REMUNERATION AND EVALUATION COMMITTEE OF THE BOARD OF DIRECTORS

CONTINUING CONNECTED TRANSACTIONS AND CONNECTED TRANSACTION

CONTINUING CONNECTED TRANSACTIONS AND CONNECTED TRANSACTION

PROPOSED PARTIAL REPURCHASE AND CANCELLATION OF THE RESTRICTED A SHARES

PROPOSED PARTIAL REPURCHASE AND CANCELLATION OF THE RESTRICTED A SHARES

(1) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND (3) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURES FOR THE GENERAL MEETING OF SHAREHOLDERS

(1) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND (3) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURES FOR THE GENERAL MEETING OF SHAREHOLDERS

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2023

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2023

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2023

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2023

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top